The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1001193112 10011931 12 F 20140127 20140620 20140314 20140630 EXP PHHO2014NZ002978 NOVARTIS 72.88 YR F Y 60.90000 KG 20140630 N MD NZ NZ

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1001193112 10011931 1 PS AFINITOR 1 ORAL 10 MG, QD 5010 MG D 22334 10 MG TABLET QD
1001193112 10011931 2 SS AFINITOR 1 5 MG, UNK 5010 MG D 22334 5 MG TABLET
1001193112 10011931 3 C METOCLOPRAMIDE 1 20 MG, Q6H D 0 20 MG Q6H
1001193112 10011931 4 C SALBUTAMOL 1 INHALATION 2 DF (PUFFS), BID D 0 2 DF BID
1001193112 10011931 5 C PARACETAMOL 1 ORAL 1 G EVERY 20 HRS PER DAY D 0 1 G
1001193112 10011931 6 C PANTOPRAZOLO DR RED 2 40 MG, BID D 0 40 MG BID
1001193112 10011931 7 C NODIA//LOPERAMIDE HYDROCHLORIDE 2 1-2 CAPS AS REQUIRED, MAXIMUM 8 CAPS DAILY D 0 2 DF QD
1001193112 10011931 8 C ASPIRIN 1 ORAL 100 MG, QD D 0 100 MG QD
1001193112 10011931 9 C SYMBICORT TU 1 INHALATION 1 DF (PUFF), BID D 0 1 DF BID
1001193112 10011931 10 C ARROW-RANITIDINE 2 ORAL 150 MG, BID D 0 150 MG BID
1001193112 10011931 11 C NEO-MERCAZOLE 1 ORAL 5 MG, BID D 0 5 MG BID
1001193112 10011931 12 C PLENDIL ER 1 ORAL 10 MG, QD D 0 10 MG QD
1001193112 10011931 13 C METOPROLOL 1 ORAL 47.5 MG, QD D 0 47.5 MG QD
1001193112 10011931 14 C ACCURETIC 1 ORAL 1 DF, QD (10MG/12.5 MG, QD) U 0 1 DF QD
1001193112 10011931 15 C RANITIDINE 1 ORAL 150 MG, BID D 0 150 MG BID
1001193112 10011931 16 C BUDESONIDE W/FORMOTEROL FUMARATE 1 BID D 0
1001193112 10011931 17 C FELODIPINE 1 ORAL 10 MG, QD D 0 10 MG QD
1001193112 10011931 18 C METFORMIN 1 ORAL 500 MG, BID U 0 500 MG BID
1001193112 10011931 19 C OMEPRAZOLE 1 ORAL 40 MG, QD D 0 40 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1001193112 10011931 1 Pancreatic neuroendocrine tumour metastatic
1001193112 10011931 3 Nausea
1001193112 10011931 6 Peptic ulcer
1001193112 10011931 7 Diarrhoea
1001193112 10011931 13 Blood pressure
1001193112 10011931 15 Peptic ulcer
1001193112 10011931 16 Asthma
1001193112 10011931 17 Blood pressure

Outcome of event

Event ID CASEID OUTC COD
1001193112 10011931 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
1001193112 10011931 Duodenal ulcer
1001193112 10011931 Gastroenteritis aeromonas
1001193112 10011931 Oesophagitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1001193112 10011931 1 20121009 20140221 0
1001193112 10011931 2 20140304 20140402 0